Received Feb 25, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | 1 | UNK | — |
Headache; Shivers; Fever; severely tired; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of headache in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, 8 hrs after receiving Shingles vaccine, the patient experienced headache (Verbatim: Headache), shivers (Verbatim: Shivers), fever (Verbatim: Fever) and tiredness (Verbatim: severely tired). The outcome of the headache, shivers, fever and tiredness were resolved. It was unknown if the reporter considered the headache, shivers, fever and tiredness to be related to Shingles vaccine. It was unknown if the company considered the headache, shivers, fever and tiredness to be related to Shingles vaccine. Linked case(s) involving the same patient:US2026AMR025378 Additional Information: GSK Receipt Date: 20-FEB-2026 This case was reported by a patient via interactive digital media. The patient had fever, headache, shivers and severely tired approximately 8 hours after both shots and symptoms lasted 24 hours. The reporter stated that still way better than getting the shingles as he/she had seen several people got the shingles and it looked horribly painful. The batch number was not provided, and we are unable to contact the reporter. For tolerance of 2nd dose of Shingles vaccine, refer case US2026AMR025378. The case had been linked to US2026AMR025381, reported by the same reporter, for a different patient.; Sender's Comments: US-GSK-US2026AMR025381:Original Case Number : US2026AMR025375 US-GSK-US2026AMR025378: